CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS

CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS

Show other versions (1)

To determine the clinical features and treatment outcomes of infant with immune thrombo-cytopenic purpura (ITP). Retrospective analysis of 96 infant ITP patients treated from 1995 to 2005. The data abstracted comprised age, gender, clinical features, and treatment outcomes. The 56 male and 40 female...

Full description

Bibliographic Details
Main Author: A. Ramyar N. Kalantari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2007-09-01
Series:Acta Medica Iranica
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5787.pdf&manuscript_id=5787
id doaj-116e83b69a744ddb863e4d28e9d3b011
record_format Article
spelling doaj-116e83b69a744ddb863e4d28e9d3b0112020-11-25T01:50:39ZengTehran University of Medical SciencesActa Medica Iranica0044-60252007-09-01456510512CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTSA. Ramyar N. KalantariTo determine the clinical features and treatment outcomes of infant with immune thrombo-cytopenic purpura (ITP). Retrospective analysis of 96 infant ITP patients treated from 1995 to 2005. The data abstracted comprised age, gender, clinical features, and treatment outcomes. The 56 male and 40 female infants had a median age of 3 months. Eighty presented with purpura, sixteen with active mucosal bleeding. The median platelet count was 13000 /l. Seventy-seven infants received intravenous immunoglobulin (IVIG), eighteen steroids and one patient was observed. Ninty-sex (96%) responds to a single course of treatment. Infant with ITP respond favorably to treatment.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5787.pdf&manuscript_id=5787
collection DOAJ
language English
format Article
sources DOAJ
author A. Ramyar N. Kalantari
spellingShingle A. Ramyar N. Kalantari
CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
Acta Medica Iranica
author_facet A. Ramyar N. Kalantari
author_sort A. Ramyar N. Kalantari
title CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
title_short CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
title_full CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
title_fullStr CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
title_full_unstemmed CLINICAL FEATURES AND TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIC PURPURA IN INFANTS
title_sort clinical features and treatment response of immune thrombocytopenic purpura in infants
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
publishDate 2007-09-01
description To determine the clinical features and treatment outcomes of infant with immune thrombo-cytopenic purpura (ITP). Retrospective analysis of 96 infant ITP patients treated from 1995 to 2005. The data abstracted comprised age, gender, clinical features, and treatment outcomes. The 56 male and 40 female infants had a median age of 3 months. Eighty presented with purpura, sixteen with active mucosal bleeding. The median platelet count was 13000 /l. Seventy-seven infants received intravenous immunoglobulin (IVIG), eighteen steroids and one patient was observed. Ninty-sex (96%) responds to a single course of treatment. Infant with ITP respond favorably to treatment.
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5787.pdf&manuscript_id=5787
work_keys_str_mv AT aramyarnkalantari clinicalfeaturesandtreatmentresponseofimmunethrombocytopenicpurpuraininfants
_version_ 1725000648124006400

Similar Items